Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Supplement
-
Reference no. 9-399-174
Published by: Harvard Business Publishing
Originally published in: 1999
Version: 20 October 1999

Abstract

Examines major issues faced by Eli Lilly as it evaluates the appropriateness of a focused matrix organization with extensive use of cross-functional teams.
Industry:
Size:
USD12 billion revenues, 10,000 employees
Other setting(s):
1998

About

Abstract

Examines major issues faced by Eli Lilly as it evaluates the appropriateness of a focused matrix organization with extensive use of cross-functional teams.

Settings

Industry:
Size:
USD12 billion revenues, 10,000 employees
Other setting(s):
1998

Related